These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23895190)

  • 1. β-Lactamase inhibitors: an update.
    Chen J; Shang X; Hu F; Lao X; Gao X; Zheng H; Yao W
    Mini Rev Med Chem; 2013 Nov; 13(13):1846-61. PubMed ID: 23895190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.
    Bebrone C; Lassaux P; Vercheval L; Sohier JS; Jehaes A; Sauvage E; Galleni M
    Drugs; 2010 Apr; 70(6):651-79. PubMed ID: 20394454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactamase inhibitors: the story so far.
    Pérez-Llarena FJ; Bou G
    Curr Med Chem; 2009; 16(28):3740-65. PubMed ID: 19747143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors.
    Sandanayaka VP; Prashad AS
    Curr Med Chem; 2002 Jun; 9(12):1145-65. PubMed ID: 12052169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactamase inhibitors: agents to overcome bacterial resistance.
    Maiti SN; Phillips OA; Micetich RG; Livermore DM
    Curr Med Chem; 1998 Dec; 5(6):441-56. PubMed ID: 9873109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New promising β-lactamase inhibitors for clinical use.
    Olsen I
    Eur J Clin Microbiol Infect Dis; 2015 Jul; 34(7):1303-8. PubMed ID: 25864193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tackling the Antibiotic Resistance Caused by Class A
    Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lactamase inhibitors: evolving compounds for evolving resistance targets.
    Georgopapadakou NH
    Expert Opin Investig Drugs; 2004 Oct; 13(10):1307-18. PubMed ID: 15461559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
    Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
    Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
    Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
    Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.
    Buynak JD
    Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
    Salahuddin P; Kumar A; Khan AU
    Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three decades of beta-lactamase inhibitors.
    Drawz SM; Bonomo RA
    Clin Microbiol Rev; 2010 Jan; 23(1):160-201. PubMed ID: 20065329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of antibiotic resistance and beta-lactamase inhibition by mechanism-based inactivators: perspectives and future directions.
    Therrien C; Levesque RC
    FEMS Microbiol Rev; 2000 Jul; 24(3):251-62. PubMed ID: 10841972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor resistant class A beta-lactamases.
    Bonomo RA; Rice LB
    Front Biosci; 1999 May; 4():e34-41. PubMed ID: 10331993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A broad-spectrum peptide inhibitor of beta-lactamase identified using phage display and peptide arrays.
    Huang W; Beharry Z; Zhang Z; Palzkill T
    Protein Eng; 2003 Nov; 16(11):853-60. PubMed ID: 14631075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase.
    Werner JP; Mitchell JM; Taracila MA; Bonomo RA; Powers RA
    Protein Sci; 2017 Mar; 26(3):515-526. PubMed ID: 27997706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel imidazole substituted 6-methylidene-penems as broad-spectrum beta-lactamase inhibitors.
    Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Yamamura I; Kumagai T; Petersen PJ; Weiss WJ; Lenoy E; Yang Y; Shlaes DM; Ryan JL; Mansour TS
    Bioorg Med Chem; 2004 Nov; 12(22):5807-17. PubMed ID: 15498657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
    Helfand MS; Taracila MA; Totir MA; Bonomo RA; Buynak JD; van den Akker F; Carey PR
    Biochemistry; 2007 Jul; 46(29):8689-99. PubMed ID: 17595114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.